UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 20, 2004
IMCLONE SYSTEMS INCORPORATED |
(Exact name of Registrant as Specified in Charter) |
| | | | |
Delaware | | 0-19612 | | 04-2834797 |
(State of incorporation or
organization) | | (Commission File Number) | | (I.R.S. Employer Identification
No.) |
| | | | |
180 Varick Street, 6th Floor |
New York, New York 10014 |
(Address of Principal Executive Offices) (Zip Code) |
| | | | |
(212) 645-1405 |
(Registrant’s telephone number, including area code) |
| | | | |
N/A |
(Former Name or Former Address, if Changed Since Last Report) |
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
| Exhibit No. | | Exhibit Title |
| | | |
| 99.1 | | Press release of ImClone Systems Incorporated dated July 20, 2004. |
Item 9. Regulation FD Disclosure
On July 20, 2004, ImClone Systems Incorporated (the “Company”) and Bristol-Myers Squibb Company issued a press release announcing that the companies have established a plan for the filing of a supplemental Biologics License Application (sBLA) for use of ERBITUX as a single agent and in combination with radiation in Squamous Cell Carcinoma of the Head and Neck (SCCHN) with the U.S. Food and Drug Administration (FDA). A copy of the press release is attached as Exhibit 99.1 hereto.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| IMCLONE SYSTEMS INCORPORATED |
| | | |
| By: | /s/ Clifford R. Saffron |
| | Name: | Clifford R. Saffron |
| | Title: | Senior Vice President, Legal |
| | | and General Counsel |
| | | |
Date: July 21, 2004 | | | |
| | | | |
3
EXHIBIT INDEX
| Exhibit No. | | Exhibit Title |
| | | |
| 99.1 | | Press release of ImClone Systems Incorporated dated July 20, 2004. |
4
